|
Canada-0-BAILIFFS ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- Drug Approvals and Databases | FDA
Downloadable data files FDA Adverse Event Reporting System (FAERS) Public Dashboard Inactive Ingredient Search for Approved Drug Products Search More information Medication Guides Search More
- Novel Drug Approvals for 2025 | FDA
FDA Novel Drug Therapy Approvals for 2025 In 2025, CDER approved 46 new drugs never before approved or marketed in the U S , known as “novel” drugs
- FDA-Approved Treatments for Alzheimers
FDA-Approved Drugs For Alzheimer's The FDA has approved medications that fall into two categories: drugs that change disease progression in people living with early Alzheimer's disease, and drugs that may temporarily mitigate some symptoms of Alzheimer's dementia
- FDA approves Wellcovorin for ultra-rare disease. The Trump . . .
The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same
- Drugs@FDA - Food and Drug Administration
Drugs@FDA includes most of the drug products approved since 1939 The majority of patient information, labels, approval letters, reviews, and other information are available for drug products approved since 1998
- New FDA Drug Approvals for 2026 - Drugs. com
Up to date information on the latest FDA drug approvals Includes list of most recent approvals, the conditions approved for, and the approval history
- FDA approves Denali Hunter syndrome drug - fiercepharma. com
The FDA has approved Denali Therapeutics’ enzyme replacement therapy for a genetic lysosomal storage disease after a string of high-profile rejections for rare disease candidates In approving
- UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA . . .
"The FDA approval of UPLIZNA marks a significant turning point for IgG4-RD patients and physicians who now have a proven treatment that targets a key driver of the disease, reducing the risk of flares and reliance on harmful long-term steroid use," said Jay Bradner, M D , executive vice president of Research and Development at Amgen
- FDA Approves Ozempic For Type 2 Diabetes and Chronic Kidney . . .
On January 28, 2025, the U S Food and Drug Administration (FDA) approved Ozempic for use in people with type 2 diabetes and kidney disease This approval marks an important milestone in kidney disease treatment, offering a new option to help reduce complications like heart disease, dialysis, or kidney transplant
- Drugs | FDA - U. S. Food and Drug Administration
Drugs@FDA Find information about most FDA-approved prescription, generic, and over-the-counter drug products Drug Shortages Find information about drug shortages caused by manufacturing and
|
|